Literature DB >> 12626389

Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.

Nico Callewaert1, Els Schollen, Annelies Vanhecke, Jaak Jaeken, Gert Matthijs, Roland Contreras.   

Abstract

The N-glycans present on the total mixture of serum glycoproteins (serum N-glycome) were analyzed in 24 subjects with congenital disorder of glycosylation type I (CDG-I) and 7 healthy, age-matched individuals. No new N-glycan structures were observed in the sera of CDG-I patients as compared with normal sera. However, we observed in all subtypes a significantly increased degree of core alpha-1,6-fucosylation of the biantennary glycans as compared to normal, as well as a significant decrease in the amount of triantennary glycans. These serum N-glycome changes appear to be a milder manifestation of some of the changes observed in adult liver cirrhosis patients, which is compatible with the reported steatosis and fibrosis in CDG-I patients. In the CDG-Ia subgroup, the extent of the serum N-glycome changes correlates with the aberration of the serum transferrin isoelectric focusing pattern, which measures the severity of the lack of entire N-glycan chains (primary consequence of CDG-I) in the liver and is the standard diagnostic test for this category of inherited diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626389     DOI: 10.1093/glycob/cwg040

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  13 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Production of complex multiantennary N-glycans in Nicotiana benthamiana plants.

Authors:  Bieke Nagels; Els J M Van Damme; Martin Pabst; Nico Callewaert; Koen Weterings
Journal:  Plant Physiol       Date:  2011-01-13       Impact factor: 8.340

3.  ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines.

Authors:  Daniah Albokhari; Bobby G Ng; Alis Guberinic; Earnest James Paul Daniel; Nicole M Engelhardt; Rita Barone; Agata Fiumara; Livia Garavelli; Gabriele Trimarchi; Lynne Wolfe; Kimiyo M Raymond; Eva Morava; Miao He; Hudson H Freeze; Christina Lam; Andrew C Edmondson
Journal:  J Inherit Metab Dis       Date:  2022-06-30       Impact factor: 4.750

4.  Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.

Authors:  Dirk J Lefeber; Johannes Schönberger; Eva Morava; Mailys Guillard; Karin M Huyben; Kiek Verrijp; Olga Grafakou; Athanasios Evangeliou; Frank W Preijers; Panagiota Manta; Jef Yildiz; Stephanie Grünewald; Martha Spilioti; Christa van den Elzen; Dominique Klein; Daniel Hess; Hisashi Ashida; Jan Hofsteenge; Yusuke Maeda; Lambert van den Heuvel; Martin Lammens; Ludwig Lehle; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

5.  Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.

Authors:  Nurulamin Abu Bakar; Nicol C Voermans; Thorsten Marquardt; Christian Thiel; Mirian C H Janssen; Hana Hansikova; Ellen Crushell; Jolanta Sykut-Cegielska; Francis Bowling; Lars MØrkrid; John Vissing; Eva Morava; Monique van Scherpenzeel; Dirk J Lefeber
Journal:  Transl Res       Date:  2018-05-10       Impact factor: 7.012

6.  ALG12-CDG: novel glycophenotype insights endorse the molecular defect.

Authors:  Luisa Sturiale; Sebastiano Bianca; Domenico Garozzo; Alessandra Terracciano; Emanuele Agolini; Angela Messina; Angelo Palmigiano; Francesca Esposito; Chiara Barone; Antonio Novelli; Agata Fiumara; Jaak Jaeken; Rita Barone
Journal:  Glycoconj J       Date:  2019-09-16       Impact factor: 2.916

7.  Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.

Authors:  Hind Alsharhan; Bobby G Ng; Earnest James Paul Daniel; Jennifer Friedman; Eniko K Pivnick; Amal Al-Hashem; Eissa Ali Faqeih; Pengfei Liu; Nicole M Engelhardt; Kierstin N Keller; Jie Chen; Pamela A Mazzeo; Jill A Rosenfeld; Michael J Bamshad; Deborah A Nickerson; Kimiyo M Raymond; Hudson H Freeze; Miao He; Andrew C Edmondson; Christina Lam
Journal:  J Inherit Metab Dis       Date:  2021-03-01       Impact factor: 4.750

8.  ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes.

Authors:  Hind Alsharhan; Miao He; Andrew C Edmondson; Earnest J P Daniel; Jie Chen; Tyhiesia Donald; Somayeh Bakhtiari; David J Amor; Elizabeth A Jones; Grace Vassallo; Marie Vincent; Benjamin Cogné; Wallid Deb; Arend H Werners; Sheng C Jin; Kaya Bilguvar; John Christodoulou; Richard I Webster; Katherine R Yearwood; Bobby G Ng; Hudson H Freeze; Michael C Kruer; Dong Li; Kimiyo M Raymond; Elizabeth J Bhoj; Andrew K Sobering
Journal:  J Inherit Metab Dis       Date:  2021-03-26       Impact factor: 4.750

9.  Fibrotic response in fibroblasts from congenital disorders of glycosylation.

Authors:  M Rita Lecca; Charlotte Maag; Eric G Berger; Thierry Hennet
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

10.  Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.

Authors:  Wendy E Heywood; Emily Bliss; Philippa Mills; Jale Yuzugulen; Gabriela Carreno; Peter T Clayton; Francesco Muntoni; Viki C Worthington; Silvia Torelli; Neil J Sebire; Kevin Mills; Stephanie Grunewald
Journal:  Mol Genet Metab Rep       Date:  2016-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.